Title	Response evaluation week 10
Number of Patients Screened	30
Number of Patients Enrolled	27
Number of Patients Evaluable for Toxicity	26
Number of Patients Evaluated for Efficacy	26
Evaluation Method	RECIST 1.1
Response Assessment CR	n = 0 (0%)
Response Assessment PR	n = 0 (0%)
Response Assessment SD	n = 5 (19%)
Response Assessment PD	n = 13 (50%)
Response Assessment OTHER	n = 8 (31%)
(Median) Duration Assessments PFS	70 days, CI: 69–71
(Median) Duration Assessments TTP	69 days, CI: 55–85
(Median) Duration Assessments OS	157 days, CI: 117–197
(Median) Duration Assessments Duration of Treatment	70 days
Outcome Notes	Other category specified: Early death from malignant disease (n = 3) Early death from other cause (n = 1) Not assessable (withdrew consent) (n = 2) Not assessable (rapid clinical deterioration) (n = 1) Not assessable (off‐study after infections) (n = 1)